Literature DB >> 28707147

The HLA-G 14-bp polymorphism and recurrent implantation failure: a meta-analysis.

Wei Fan1, Zhongying Huang1, Shangwei Li1, Zhun Xiao2.   

Abstract

PURPOSE: The human leucocyte antigen-G (HLA-G) 14-bp insertion/deletion polymorphism was implicated in recurrent implantation failure (RIF), but individual published studies showed inconclusive results. Thus, a meta-analysis was performed to clarify the effect of HLA-G 14-bp polymorphism on RIF risk.
METHODS: A comprehensive search for relevant articles was conducted. The odds ratios (ORs) and 95% confidence intervals (CIs) for HLA-G 14-bp polymorphism and RIF were calculated.
RESULTS: A total of five studies were included. In studies conducted in RIF patients and controls who had at least one spontaneous pregnancy, meta-analysis revealed no statistically significant association between the HLA-G 14-bp polymorphism and RIF in allele contrast and all genetic models in the overall population, but significant association was found in the population of Caucasian origin under allele contrast (OR = 1.73, 95% CI, 1.20, 2.50) and genetic models of +14 bp/+14 bp vs. -14 bp/-14 bp (OR = 3.09, 95% CI, 1.43, 6.65). In studies conducted in RIF patients and controls who had successful pregnancy following IVF-ET, the meta-analysis showed that there was statistically significant association between the HLA-G 14 bp polymorphism and RIF in allele contrast (OR = 1.74, 95% CI, 1.13, 2.67) and genetic models of +14 bp/+14 bp vs. -14 bp/-14 bp (OR = 10.20, 95% CI, 2.47, 42.14) and dominant model (OR = 4.34, 95% CI, 1.72, 10.92). No publication bias was found in the present studies.
CONCLUSIONS: This meta-analysis suggested that the HLA-G 14-bp insertion allele may increase the risk of RIF in Caucasians. Further studies with large sample size of different ethnic populations are necessary.

Entities:  

Keywords:  HLA-G; Polymorphism; RIF

Mesh:

Substances:

Year:  2017        PMID: 28707147      PMCID: PMC5700002          DOI: 10.1007/s10815-017-0994-3

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  34 in total

1.  HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels.

Authors:  Thomas Vauvert F Hviid; Sine Hylenius; Christina Rørbye; Lone G Nielsen
Journal:  Immunogenetics       Date:  2003-04-24       Impact factor: 2.846

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

3.  The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma.

Authors:  X-Y Chen; W-H Yan; A Lin; H-H Xu; J-G Zhang; X-X Wang
Journal:  Tissue Antigens       Date:  2008-08-12

4.  Degree of TNF-α/IL-10 cytokine elevation correlates with IVF success rates in women undergoing treatment with Adalimumab (Humira) and IVIG.

Authors:  Edward E Winger; Jane L Reed; Sherif Ashoush; Tarek El-Toukhy; Sapha Ahuja; Mohamed Taranissi
Journal:  Am J Reprod Immunol       Date:  2011-01-12       Impact factor: 3.886

5.  Analysis of HLA-G polymorphisms in couples with implantation failure.

Authors:  Fabiola da Silva Nardi; Renata Slowik; Pryscilla Fanini Wowk; José Samuel da Silva; Geórgia Fernanda Gelmini; Tatiana Ferreira Michelon; Jorge Neumann; Maria da Graça Bicalho
Journal:  Am J Reprod Immunol       Date:  2012-09-25       Impact factor: 3.886

6.  Secretion of human leukocyte antigen-G by human embryos is associated with a higher in vitro fertilization pregnancy rate.

Authors:  Shang-mian Yie; Hanna Balakier; Gelareh Motamedi; Clifford L Librach
Journal:  Fertil Steril       Date:  2005-01       Impact factor: 7.329

7.  Association of miR-146aC>G, miR-149C>T, miR-196a2T>C, and miR-499A>G polymorphisms with risk of recurrent implantation failure in Korean women.

Authors:  Sung Hwan Cho; Ki Wha Chung; Jung Oh Kim; Hyogeun Jang; Jung Ki Yoo; Youngsok Choi; Jung Jae Ko; Ji Hyang Kim; Yoshihiro Nishi; Toshihiko Yanase; Woo Sik Lee; Nam Keun Kim
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2016-04-25       Impact factor: 2.435

8.  HLA-G has a concentration-dependent effect on the generation of an allo-CTL response.

Authors:  K Kapasi; S E Albert; S Yie; N Zavazava; C L Librach
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

9.  The Relationship between HLA-G Gene Polymorphisms and Repeated Implantation Failure in Infertile Couples Undergoing Assisted Reproductive Technique.

Authors:  Zahra Kuroshli; Hamid Gourabi; Masood Bazrgar; MohammadHossein Sanati; Masoud Zamani Esteki
Journal:  Iran J Allergy Asthma Immunol       Date:  2015-10       Impact factor: 1.464

10.  Association of the maternal 14-bp insertion/deletion polymorphism in the histocompatibility leukocyte antigen G gene with recurrent implantation failure.

Authors:  Mahbubeh Enghelabifar; Somaiieh Allafan; Jina Khayatzadeh; Khadijeh Shahrokh Abadi; Mohammad Hasanzadeh Nazarabadi; Fahimeh Moradi; Nozhat Musavifar; Mohsen Jalali; Majid Mojarrad
Journal:  Iran J Reprod Med       Date:  2014-09
View more
  3 in total

1.  Association of Soluble HLA-G Plasma Level and HLA-G Genetic Polymorphism With Pregnancy Outcome of Patients Undergoing in vitro Fertilization Embryo Transfer.

Authors:  Izabela Nowak; Karolina Wilczyńska; Paweł Radwan; Andrzej Wiśniewski; Rafał Krasiński; Michał Radwan; Jacek R Wilczyński; Andrzej Malinowski; Piotr Kuśnierczyk
Journal:  Front Immunol       Date:  2020-01-14       Impact factor: 7.561

2.  Abnormal Cullin1 neddylation-mediated p21 accumulation participates in the pathogenesis of recurrent spontaneous abortion by regulating trophoblast cell proliferation and differentiation.

Authors:  Xiaohe Sun; Xiaomei Tong; Yanqing Hao; Chao Li; Yinli Zhang; Yibin Pan; Yongdong Dai; Liu Liu; Tai Zhang; Songying Zhang
Journal:  Mol Hum Reprod       Date:  2020-05-15       Impact factor: 4.025

Review 3.  Roles of HLA-G in the Maternal-Fetal Immune Microenvironment.

Authors:  Xiuxiu Xu; Yonggang Zhou; Haiming Wei
Journal:  Front Immunol       Date:  2020-10-22       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.